Once again the European Heart Journal has “unpublished” an article without any notice of retraction or explanation. Strangely, the article– Russian science through the prism of intelligence: is fraud still possible?– can still be viewed (at least for now) with a vestigial URL , but it can not be found through the usual channels on the journal site. The pages for the story…
The Complicated Story Behind Yet Another Disappeared Article At A Top Heart Journal
August 12, 2014 by Leave a Comment
Leading European Cardiologist Accused Of Plagiarism
February 10, 2014 by Leave a Comment
Thomas Lüscher, the editor of the European Heart Journal and one of the most prominent cardiologists in Europe, has been accused of plagiarism. An irony in the case is that Lüscher has taken a strong public position against scientific misconduct of all sorts, including plagiarism. … Click here to read the full post on Forbes. …
This Blog Is ‘Not Suitable For Dissemination Through The Internet’
February 9, 2014 by 1 Comment
The editors of the prestigious European Heart Journal have decided that this blog, or at least one recent post, “is “not suitable for dissemination through the internet.” I beg to differ. In an EHJ editorial, Is the panic about beta-blockers in perioperative care justified?, the authors, the editors of the journal, led by editor-in-chief Thomas Lüscher, repeatedly criticize a post I wrote…
Lancet Formally Retracts Jikei Heart Study Of Valsartan
September 5, 2013 by Leave a Comment
The Lancet has formally retracted the Jikei Heart Study paper, originally published in 2007. The retraction had been widely anticipated for more than a month, after a series of news reports in Japan made it clear that the long-simmering controversy over scientific misconduct involving the Novartis blood pressure lowering drug valsartan (Diovan) had come to a full boil. (See our earlier story here.)…
Sex And The Cardiac Patient Should Not Be A Taboo Subject
July 29, 2013 by 3 Comments
It’s not an easy conversation to have. After a heart attack or other major cardiac event, talking about sex is awkward, and often avoided by patients, their partners, and physicians. But a new consensus statement from several major cardiology organizations urges physicians to get over their reluctance or embarrassment and counsel their cardiac patients about…
Take Your Blood Pressure Pills Or Increase Your Risk Of Stroke
July 17, 2013 by Leave a Comment
A large new observational study demonstrates that people who don’t take their antihypertensive medications are much more likely to have a stroke. The new study, published in the European Heart Journal, used nationwide prescription, hospital and mortality records from 73,527 hypertensive patients in Finland. The Finnish investigators compared 26,704 patients who were hospitalized or died of stroke…
Too Much, Too Fast? Cross-Country Skiing And Heart Arrhythmias
June 12, 2013 by 1 Comment
When it comes to exercise it may be true that you can do too much or go too fast. It may seem counterintuitive but a new study finds that among cross-country skiers the risk of having a cardiac arrhythmia was highest in those who raced the fastest or most often. … In a paper published in…
HPS2-THRIVE Coming Attraction: First Look At What Went Wrong With Niacin
February 27, 2013 by Leave a Comment
In a few weeks, on March 9, the main results of the HPS2-THRIVE (Heart Protection Study 2-Treatment of HDL to Reduce the Incidence of Vascular Events) study will be presented in San Francisco at the annual meeting of the American College of Cardiology. These results have been eagerly awaited since Merck’s brief announcement in December that the trial had not met its primary endpoint…
European Heart Journal Retracts Main Paper Of The Kyoto Heart Study
February 2, 2013 by 1 Comment
The editors of the European Heart Journal have retracted the 2009 paper reporting the main results of the Kyoto Heart Study, a randomized, open-labeled study testing the add-on effect of valsartan to conventional therapy in high-risk hypertension. The retraction notice gave no details about the problems that led to the retraction. Here is the full text…
Recent Comments